Clinical Trials
8
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Physiological Parameters in CRPS Patients Treated With Dorsal Root Ganglion Stimulation
- Conditions
- CRPS (Complex Regional Pain Syndrome) Type I
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- AZ Delta
- Target Recruit Count
- 36
- Registration Number
- NCT07147140
- Locations
- 🇧🇪
AZ Delta, Roeselare, Belgium
Botulinum Toxin Injection in the UES for R-CPD
- Conditions
- Retrograde Cricopharyngeus Dysfunction
- Interventions
- Drug: Sodium Chloride 0.9% Inj
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- AZ Delta
- Target Recruit Count
- 30
- Registration Number
- NCT06356025
- Locations
- 🇧🇪
AZ Delta, Roeselare, Belgium
Retrospective Chart Review Screening Algorithm to Assess the Prevalence of PNH-clones
- Conditions
- PNHThrombosis
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- AZ Delta
- Target Recruit Count
- 568
- Registration Number
- NCT05884060
- Locations
- 🇧🇪
AZ Delta, Roeselare, West-Vlaanderen, Belgium
Advanced Data-Aided Medicine Part Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2023-05-10
- Lead Sponsor
- AZ Delta
- Target Recruit Count
- 500
- Registration Number
- NCT05783024
- Locations
- 🇧🇪
AZ Delta, Roeselare, West-Vlaanderen, Belgium
Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring
- Conditions
- SnoringSleep-Disordered Breathing
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- AZ Delta
- Target Recruit Count
- 16
- Registration Number
- NCT05643352
- Locations
- 🇧🇪
Neus-, keel- en oorziekten, gelaats- en halschirurgie AZ Delta, Roeselare, Belgium
- Prev
- 1
- 2
- Next
News
SOPHiA GENETICS Partners with Belgium's Jessa Ziekenhuis to Advance Precision Oncology Through AI-Driven Genomic Platform
SOPHiA GENETICS has announced a strategic collaboration with Jessa Ziekenhuis, one of Belgium's largest healthcare institutions serving over 530,000 patients, to implement the SOPHiA DDM™ platform for unified next-generation sequencing workflows.